1030 related articles for article (PubMed ID: 16673056)
1. Measuring the quality of colorectal cancer screening: the importance of follow-up.
Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
[TBL] [Abstract][Full Text] [Related]
2. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
[TBL] [Abstract][Full Text] [Related]
3. Impact of comorbidity on colorectal cancer screening in the veterans healthcare system.
Fisher DA; Galanko J; Dudley TK; Shaheen NJ
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):991-6. PubMed ID: 17627900
[TBL] [Abstract][Full Text] [Related]
4. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment.
Jones RM; Mongin SJ; Lazovich D; Church TR; Yeazel MW
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):777-84. PubMed ID: 18381476
[TBL] [Abstract][Full Text] [Related]
5. Timely follow-up of positive fecal occult blood tests strategies associated with improvement.
Powell AA; Gravely AA; Ordin DL; Schlosser JE; Partin MR
Am J Prev Med; 2009 Aug; 37(2):87-93. PubMed ID: 19524390
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer screening in young patients with poor health and severe comorbidity.
Sultan S; Conway J; Edelman D; Dudley T; Provenzale D
Arch Intern Med; 2006 Nov; 166(20):2209-14. PubMed ID: 17101938
[TBL] [Abstract][Full Text] [Related]
7. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
[TBL] [Abstract][Full Text] [Related]
8. Colorectal carcinoma screening procedure use among primary care patients.
Lafata JE; Williams LK; Ben-Menachem T; Moon C; Divine G
Cancer; 2005 Oct; 104(7):1356-61. PubMed ID: 16092119
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer screening mode preferences among US veterans.
Powell AA; Burgess DJ; Vernon SW; Griffin JM; Grill JP; Noorbaloochi S; Partin MR
Prev Med; 2009 Nov; 49(5):442-8. PubMed ID: 19747502
[TBL] [Abstract][Full Text] [Related]
10. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a VHA collaborative to improve follow-up after a positive colorectal cancer screening test.
Powell AA; Nugent S; Ordin DL; Noorbaloochi S; Partin MR
Med Care; 2011 Oct; 49(10):897-903. PubMed ID: 21642875
[TBL] [Abstract][Full Text] [Related]
12. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
Levin B; Hess K; Johnson C
Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
[TBL] [Abstract][Full Text] [Related]
13. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network.
Young WF; McGloin J; Zittleman L; West DR; Westfall JM
J Rural Health; 2007; 23(3):238-45. PubMed ID: 17565524
[TBL] [Abstract][Full Text] [Related]
14. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.
Baig N; Myers RE; Turner BJ; Grana J; Rothermel T; Schlackman N; Weinberg DS
Am J Gastroenterol; 2003 Sep; 98(9):2078-81. PubMed ID: 14499791
[TBL] [Abstract][Full Text] [Related]
15. Survival of patients diagnosed with colorectal cancer through a television-advertised screening program.
Slusser SO; Liberski SM; McGarrity TJ
Am J Gastroenterol; 1996 Aug; 91(8):1563-6. PubMed ID: 8759662
[TBL] [Abstract][Full Text] [Related]
16. Trends in colorectal cancer testing among Medicare subpopulations.
Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
[TBL] [Abstract][Full Text] [Related]
17. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
18. Patterns of colorectal cancer screening uptake among men and women in the United States.
Meissner HI; Breen N; Klabunde CN; Vernon SW
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):389-94. PubMed ID: 16492934
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer screening among men and women in the United States.
Peterson NB; Murff HJ; Ness RM; Dittus RS
J Womens Health (Larchmt); 2007; 16(1):57-65. PubMed ID: 17324097
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial.
Hoffman RM; Steel S; Yee EF; Massie L; Schrader RM; Murata GH
Prev Med; 2010; 50(5-6):297-9. PubMed ID: 20307568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]